Page results
-
The department undertakes specialist dental treatment for those under 16 years of age ( 15 years and 11 months), and deals with the aetiology, prevention, diagnosis and treatment of oral disorders; mouth conditions and teeth of children.
-
The molecular genetics laboratory at UCLH is a national centre for the genetic diagnosis of haemoglobin disorders, including prenatal diagnosis.
-
This information is for patients who are receiving radiotherapy to the prostate or prostate bed. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
Radiotherapy Department Patient Information series no. 18 - prostate brachytherapy prostate high dose rate (HDR) brachytherapy
-
The lung function unit is an integral part of the department of Thoracic Medicine, offering a wide range of physiological tests to both inpatients and clinic outpatients within the Trust, to help not only in the diagnoses of lung disorders, but also to assess the severity of these conditions.
-
This page provides an overview of the Ambulatory Care Service for adult patients.
-
OPAT (Outpatient Parenteral Antimicrobial Therapy) is a safe and convenient way to receive intravenous (IV) antibiotic therapy at home or in a clinic.
-
Advice on eating better for young people living with fatigue-related conditions such as CFS and ME.
-
Paediatric Audio-vestibular Medicine provides investigation, diagnosis and management of the medical aspect of disorders of hearing, balance and tinnitus in children. The service consists of a multi-professional team and is located at The Royal National ENT & Eastman Dental Hospitals, 47-49 Huntley Street London WC1E 6DG.
-
Myeloproliferative neoplasms (MPN) are disorders that affect how the body produces red blood cells, white blood cells, and platelets.
File results
-
FOI/2022/0194 - Drug treatment for lung cancer
-
FOI/2022/0199 - Trust postal service and patient communication
-
FOI/2022/0200 - IT budget/ chatbots
-
FOI/2022/0205 - Spending on communication activities
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311